BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32376402)

  • 1. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
    Fagone P; Ciurleo R; Lombardo SD; Iacobello C; Palermo CI; Shoenfeld Y; Bendtzen K; Bramanti P; Nicoletti F
    Autoimmun Rev; 2020 Jul; 19(7):102571. PubMed ID: 32376402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
    Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W
    Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is the origin of SARS-CoV-2?].
    Torres-López J
    Rev Med Inst Mex Seguro Soc; 2020 Jan; 58(1):1-2. PubMed ID: 32412715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
    Husain A; Byrareddy SN
    Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
    Wu T; Zhang H; Hu E; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
    Appelberg S; Gupta S; Svensson Akusjärvi S; Ambikan AT; Mikaeloff F; Saccon E; Végvári Á; Benfeitas R; Sperk M; Ståhlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
    Emerg Microbes Infect; 2020 Dec; 9(1):1748-1760. PubMed ID: 32691695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation.
    Panda AK; Padhi A; Prusty BAK
    Clin Chim Acta; 2020 Nov; 510():60-61. PubMed ID: 32653483
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
    Singal CMS; Jaiswal P; Seth P
    ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.
    Santurro A; Scopetti M; D'Errico S; Fineschi V
    Forensic Sci Med Pathol; 2020 Sep; 16(3):471-476. PubMed ID: 32399755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
    Yuan J; Fan D; Xue Z; Qu J; Su J
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):13. PubMed ID: 33049061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
    Majdic G
    Front Cell Infect Microbiol; 2020; 10():327. PubMed ID: 32582576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.
    Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.